The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
![The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe](https://www.ohe.org/wp-content/uploads/2023/06/NGS-report_AdobeStock_406823942_portrait.jpg)
We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.